Fernando H. Munoz

Aosta, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Predictors of acute lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a real-world prospective multi-centric study.

Predictors of acute lymphopenia after radiotherapy for prostate cancer including pelvic node irradiation: results of a real-world prospective multi-centric study.

Journal: ESMO real world data and digital oncology

Published: April 03, 2026

Are we ready for stereotactic body radiotherapy in unfavorable intermediate and high-risk prostate patient cancer?

Are we ready for stereotactic body radiotherapy in unfavorable intermediate and high-risk prostate patient cancer?

Journal: Minerva urology and nephrology

Published: November 27, 2025

Can Deep Learning-Based Auto-Contouring Software Achieve Accurate Pelvic Volume Delineation in Volumetric Image-Guided Radiotherapy for Prostate Cancer? A Preliminary Multicentric Analysis.

Can Deep Learning-Based Auto-Contouring Software Achieve Accurate Pelvic Volume Delineation in Volumetric Image-Guided Radiotherapy for Prostate Cancer? A Preliminary Multicentric Analysis.

Journal: Current oncology (Toronto, Ont.)

Published: April 16, 2025

Metastasis-Directed Therapy in Oligometastatic Prostate Cancer: Biological Rationale and Systematic Review of Published Data.

Metastasis-Directed Therapy in Oligometastatic Prostate Cancer: Biological Rationale and Systematic Review of Published Data.

Journal: Cancers

Published: March 01, 2025

Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort study.

Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort study.

Journal: Prostate cancer and prostatic diseases

Published: January 04, 2025

Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer.

Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: February 02, 2024

Treatment options in first-line metastatic renal carcinoma: A meta-analysis of 2556 patients treated with immune checkpoint inhibitors-based combinations in randomised controlled trials.

Treatment options in first-line metastatic renal carcinoma: A meta-analysis of 2556 patients treated with immune checkpoint inhibitors-based combinations in randomised controlled trials.

Journal: Cancer treatment reviews

Published: December 29, 2023

Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.

Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.

Journal: JAMA network open

Published: October 17, 2023

Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors.

Patient-reported persistent symptoms after radiotherapy and association with quality of life for prostate cancer survivors.

Journal: Acta oncologica (Stockholm, Sweden)

Published: October 06, 2023

Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation.

Worsening of 2-year patient-reported intestinal functionality after radiotherapy for prostate cancer including pelvic node irradiation.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: July 11, 2023

Preoperative Radiotherapy with a Simultaneous Integrated Boost Compared to Chemoradiotherapy for cT3-4 Rectal Cancer: Long-Term Results of a Multicenter Randomized Study.

Preoperative Radiotherapy with a Simultaneous Integrated Boost Compared to Chemoradiotherapy for cT3-4 Rectal Cancer: Long-Term Results of a Multicenter Randomized Study.

Journal: Cancers

Published: May 24, 2023

Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis.

Addition of New Androgen Receptor Pathway Inhibitors to Docetaxel and Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Metanalysis.

Journal: Current oncology (Toronto, Ont.)

Published: September 12, 2022

Showing 1-12 of 52

Last Updated: 09/26/2026